Predict your next investment

Venture Capital
FINANCE | Investment Firms & Funds
archventure.com

See what CB Insights has to offer

Investments

619

Portfolio Exits

112

Funds

14

Service Providers

1

About ARCH Venture Partners

ARCH Venture Partners is a premier provider of seed and early stage venture capital for technology firms, with a special competence in co-founding and building firms from start-up. The firm's mission is to deliver promising technologies from the earliest stages to successful commercial application – from concept to commerce.

ARCH Venture Partners Headquarter Location

8755 W Higgins Road Suite 1025

Chicago, Illinois, 60631,

United States

773-380-6600

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing ARCH Venture Partners

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find ARCH Venture Partners in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

ARCH Venture Partners Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

ARCH Venture Partners Rank

Research containing ARCH Venture Partners

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned ARCH Venture Partners in 7 CB Insights research briefs, most recently on Feb 3, 2021.

Latest ARCH Venture Partners News

ONI Closes $75 Million Series B Led by ARCH Venture Partners and Casdin Capital

May 10, 2022

Pioneers in observing single molecules in living cells Funds will be used to build a product portfolio that harnesses the company’s innovative technology to unlock new possibilities in therapeutic and diagnostic development as well as basic life science research The company expands its management team and board of directors with the addition of several industry veterans January 20, 2022 03:00… The post ONI Closes $75 Million Series B Led by ARCH Venture Partners and Casdin Capital appeared first on Vertical Venture Partners.

ARCH Venture Partners Investments

619 Investments

ARCH Venture Partners has made 619 investments. Their latest investment was in Remix Therapeutics as part of their Series B on May 5, 2022.

CBI Logo

ARCH Venture Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/17/2022

Series B

Remix Therapeutics

$70M

No

5

5/9/2022

Series B

Aspen Neuroscience

$147.5M

No

4

5/5/2022

Unattributed VC

Vizgen

$85.2M

No

1

4/26/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

4/14/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/17/2022

5/9/2022

5/5/2022

4/26/2022

4/14/2022

Round

Series B

Series B

Unattributed VC

Series A

Series B

Company

Remix Therapeutics

Aspen Neuroscience

Vizgen

Subscribe to see more

Subscribe to see more

Amount

$70M

$147.5M

$85.2M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

5

4

1

10

10

ARCH Venture Partners Portfolio Exits

112 Portfolio Exits

ARCH Venture Partners has 112 portfolio exits. Their latest portfolio exit was Aura Biosciences on October 29, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/29/2021

IPO

$99M

10

9/29/2021

IPO

2

8/11/2021

Acquired

$99M

2

8/10/2021

Acquired

Subscribe to see more

Subscribe to see more

10

8/6/2021

Acq - Pending

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/29/2021

9/29/2021

8/11/2021

8/10/2021

8/6/2021

Exit

IPO

IPO

Acquired

Acquired

Acq - Pending

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

10

2

2

10

10

ARCH Venture Partners Acquisitions

1 Acquisition

ARCH Venture Partners acquired 1 company. Their latest acquisition was Caliper Life Sciences on May 01, 1998.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

5/1/1998

Private Equity

$99M

$37.09M

Acquired

Date

5/1/1998

Investment Stage

Private Equity

Companies

Valuation

$99M

Total Funding

$37.09M

Note

Acquired

Sources

ARCH Venture Partners Fund History

14 Fund Histories

ARCH Venture Partners has 14 funds, including ARCH Venture Fund XI.

Closing Date

Fund

Fund Type

Status

Amount

Sources

1/28/2021

ARCH Venture Fund XI

$1,850M

2

10/28/2019

ARCH Venture Fund X

Early-Stage Venture Capital

Open

$636M

3

10/25/2019

ARCH Venture Fund X Overage

$635.75M

3

11/18/2016

ARCH Venture Fund IX

Subscribe to see more

Subscribe to see more

$99M

10

8/27/2014

ARCH Venture Fund VIII

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

1/28/2021

10/28/2019

10/25/2019

11/18/2016

8/27/2014

Fund

ARCH Venture Fund XI

ARCH Venture Fund X

ARCH Venture Fund X Overage

ARCH Venture Fund IX

ARCH Venture Fund VIII

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Status

Open

Subscribe to see more

Subscribe to see more

Amount

$1,850M

$636M

$635.75M

$99M

$99M

Sources

2

3

3

10

10

ARCH Venture Partners Service Providers

1 Service Provider

ARCH Venture Partners has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

Partnership data by VentureSource

ARCH Venture Partners Team

11 Team Members

ARCH Venture Partners has 11 team members, including current Founder, Managing Director, Keith L. Crandell.

Name

Work History

Title

Status

Clinton W. Bybee

Founder

Current

Keith L. Crandell

Founder, Managing Director

Current

Robert Nelson

Founder

Current

Kristina Burow

Managing Director

Current

Steve Gillis

Managing Director

Current

Name

Clinton W. Bybee

Keith L. Crandell

Robert Nelson

Kristina Burow

Steve Gillis

Work History

Title

Founder

Founder, Managing Director

Founder

Managing Director

Managing Director

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.